Arrowhead Pharmaceuticals Inc ARWR:NASDAQ

RT Quote | NASDAQ | USD
Last | 04/19/21 EDT
67.00quote price arrow down-0.65 (-0.96%)
Volume
494,443
52 week range
30.83 - 92.60

...

Loading . . .
  • Open66.49
  • Day High68.45
  • Day Low65.91
  • Prev Close67.00
  • 52 Week High92.60
  • 52 Week High Date02/10/21
  • 52 Week Low30.83
  • 52 Week Low Date06/12/20

Key Stats

  • Market Cap6.954B
  • Shares Out103.79M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-12.68

KEY STATS

  • Open66.49
  • Day High68.45
  • Day Low65.91
  • Prev Close67.00
  • 52 Week High92.60
  • 52 Week High Date02/10/21
  • 52 Week Low30.83
  • 52 Week Low Date06/12/20
  • Market Cap6.954B
  • Shares Out103.79M
  • 10 Day Average Volume0.55M
  • Dividend-
  • Dividend Yield-
  • Beta1.24
  • YTD % Change-12.68

RATIOS/PROFITABILITY

  • EPS (TTM)-1.00
  • P/E (TTM)-66.75
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-105.828M
  • ROE (MRQ)-21.50%
  • Revenue (MRQ)79.84M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-128.52%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date05/04/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest From Arrowhead Pharmaceuticals Inc

There is no recent news for this security.

Latest From Our Partners

Profile

MORE
Arrowhead Pharmaceuticals, Inc., formerly Arrowhead Research Corporation, develops medicines that treat intractable diseases by silencing the genes that cause them. Using a portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, the Company's therapies trigger the RNA interference mechanism to induce knockdown of target genes. The Company is focused on developing drugs for diseases with a genetic basis, characterized by the overproduction of one or more...
Douglass Given M.D., Ph.D.
Chairman
Christopher Anzalone Ph.D.
Chief Executive Officer
Kenneth Myszkowski
Chief Financial Officer
Address
177 E Colorado Blvd, Suite 700
Pasadena, CA
91105
United States

Top Peers

SYMBOLLASTCHG%CHG
XLRN
Acceleron Pharma Inc
120.28-1.77-1.45%
FATE
Fate Therapeutics Inc
79.65-1.52-1.87%
TWST
Twist Bioscience Corp
127.66-7.58-5.60%
BBIO
BridgeBio Pharma Inc
55.51+0.39+0.71%
PACB
Pacific Biosciences of California Inc
29.61-1.92-6.09%